Reduction of the Carbapenemase Inactivation Method (CIM) assay time by real-time PCR.

Antimicrobial resistance Carbapenemase Inactivation Method (CIM) PCR natCIM

Journal

Journal of microbiological methods
ISSN: 1872-8359
Titre abrégé: J Microbiol Methods
Pays: Netherlands
ID NLM: 8306883

Informations de publication

Date de publication:
06 Oct 2020
Historique:
received: 01 09 2020
revised: 29 09 2020
accepted: 30 09 2020
pubmed: 9 10 2020
medline: 9 10 2020
entrez: 8 10 2020
Statut: aheadofprint

Résumé

Carbapenemase Inactivation Method (CIM) is a test to detect presence of the carbapenemase in Gram-negative bacteria. Determination of the carbapenemase production by inactivation of meropenem requires that a zone of control E. coli inhibition be measured approximately 6-24 h after plating. We have modified the CIM test by developing a rapid method which instead measures the growth of E. coli indicator strain ATCC 25922 using real-time PCR, referred to as a nucleic acid testing CIM (natCIM). Our natCIM, therefore reduces the detecting time from 6 to 24 h to approximately 4 h.

Identifiants

pubmed: 33031896
pii: S0167-7012(20)30788-0
doi: 10.1016/j.mimet.2020.106072
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106072

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

F Haque (F)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

S Fisseha (S)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

P Athamanolap (P)

Department of Biomedical Engineering, Faculty of Engineering, Mahidol University, 999 Phuttamonthon4 Road, Salaya, Nakhon Pathom 73170, Thailand.

R Tower (R)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

J Ortega (J)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

C Dominguez (C)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

T Maruca (T)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

D Torpey (D)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

R Myers (R)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America.

P Laksanalamai (P)

Maryland Department of Health, Laboratories Administration, 1770 Ashland Ave., Baltimore, MD 21205, United States of America. Electronic address: pongpan.laksanalamai@maryland.gov.

Classifications MeSH